62
Growth Score in past quarter
pts
Heat Score 62 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
736069
Neuromonics, Inc. is a medical device company.
Ben Gust: Chair of the Audit Committee- Jack Springer: CEO
About the Company
Neuromonics, Inc. is a medical device company dedicated to helping people with its treatments for ringing in the ears, clinically known as tinnitus.
Neuromonics manufactures and distributes the only FDA-cleared, patented and clinically proven medical devices designed for long-term, significant relief of tinnitus. The company also has received
regulatory approval from the Therapeutic Goods Administration (TGA) in Australia.
Beginning with the work of Paul Davis, Ph.D., inventor of the Neuromonics Tinnitus Treatment, and research and development since the early 1990s, Neuromonics has helped thousands of tinnitus sufferers around the world improve their quality of life and overcome the daily challenges associated with tinnitus.